BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alvarez-Jiménez M, Hetrick SE, González-Blanch C, Gleeson JF, McGorry PD. Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry 2008;193:101-7. [PMID: 18669990 DOI: 10.1192/bjp.bp.107.042853] [Cited by in Crossref: 211] [Cited by in F6Publishing: 221] [Article Influence: 14.1] [Reference Citation Analysis]
Number Citing Articles
1 Browne J, Xie H, Wolfe RS, Naslund JA, Gorin AA, Aschbrenner KA. Factors associated with weight gain prevention in young adults with serious mental illness. Early Interv Psychiatry 2023;17:39-46. [PMID: 35347848 DOI: 10.1111/eip.13289] [Reference Citation Analysis]
2 Rodrigues AM, Kemp E, Aquino MRJ, Wilson R, Vasiljevic M, McBride K, Robson C, Loraine M, Harland J, Haighton C. Understanding the implementation of 'Making Every Contact Count' (MECC) delivered by healthcare professionals in a mental health hospital: protocol for a pragmatic formative process evaluation. Health Psychol Behav Med 2023;11:2174698. [PMID: 36760477 DOI: 10.1080/21642850.2023.2174698] [Reference Citation Analysis]
3 Shymko G, Dobson L, Acacio MC, Grace T, Tadier S, Waters F. Weight changes in people with early psychosis treated with oral or long-acting injectable aripiprazole. Schizophr Res 2023;251:74-81. [PMID: 36587541 DOI: 10.1016/j.schres.2022.11.018] [Reference Citation Analysis]
4 Inoue M, Li MH, Layman S, Tompkins CJ, Ihara ES. Characteristics of Nursing Facilities and Staff Willingness to Implement a Non-Pharmacological Intervention. Gerontol Geriatr Med 2022;8:23337214221146410. [PMID: 36582661 DOI: 10.1177/23337214221146410] [Reference Citation Analysis]
5 Meepring S, Gray R, Li Y, Ho G, Chien WT, Bressington D. Cardiometabolic health risks, lifestyle behaviours and quality of life in people diagnosed with early psychosis - A cross-sectional study. J Psychiatr Ment Health Nurs 2022;29:578-91. [PMID: 34854171 DOI: 10.1111/jpm.12809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Burrows T, Teasdale S, Rocks T, Whatnall M, Schindlmayr J, Plain J, Latimer G, Roberton M, Harris D, Forsyth A. Effectiveness of dietary interventions in mental health treatment: A rapid review of reviews. Nutr Diet 2022;79:279-90. [PMID: 35796181 DOI: 10.1111/1747-0080.12754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Richardson KA, Mckibbin CL, Dabrowski BS, Punke ELA, Hartung CM. Parent Intention to Enroll in an Online Intervention to Enhance Health Behavior Change among Youth Treated with Psychotropic Medication Who Are Overweight or Obese: An Elicitation Study. IJERPH 2022;19:8057. [DOI: 10.3390/ijerph19138057] [Reference Citation Analysis]
8 Waite F, Langman A, Mulhall S, Glogowska M, Hartmann-Boyce J, Aveyard P, Lennox B, Kabir T, Freeman D; Oxford Cognitive Approaches to Psychosis Patient Advisory Group. The psychological journey of weight gain in psychosis. Psychol Psychother 2022;95:525-40. [PMID: 35137519 DOI: 10.1111/papt.12386] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Faden J, Serdenes R, Citrome L. Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used? Expert Rev Neurother 2022. [PMID: 35354374 DOI: 10.1080/14737175.2022.2060742] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Giusti L, Bianchini V, Aggio A, Mammarella S, Salza A, Necozione S, Alunno A, Ferri C, Casacchia M, Roncone R. Twelve-month outcomes in overweight/obese users with mental disorders following a multi-element treatment including diet, physical activity, and positive thinking: The real-world "An Apple a Day" controlled trial. Front Psychiatry 2022;13:903759. [PMID: 36081460 DOI: 10.3389/fpsyt.2022.903759] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Lee C, Piernas C, Stewart C, Michalopoulou M, Hajzadeh A, Edwards R, Aveyard P, Waite F. Identifying effective characteristics of behavioral weight management interventions for people with serious mental illness: A systematic review with a qualitative comparative analysis. Obes Rev 2022;23:e13355. [PMID: 34672069 DOI: 10.1111/obr.13355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Luciano M, Sampogna G, Amore M, Andriola I, Calcagno P, Carmassi C, Del Vecchio V, Dell'Osso L, Di Lorenzo G, Gelao B, Giallonardo V, Rossi A, Rossi R, Siracusano A, Fiorillo A; LIFESTYLE Working Group. How to improve the physical health of people with severe mental illness? A multicentric randomized controlled trial on the efficacy of a lifestyle group intervention. Eur Psychiatry 2021;64:e72. [PMID: 34812136 DOI: 10.1192/j.eurpsy.2021.2253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Midtgaard J, Schnor H, Bjerre ED, Jespersen T, Jelsøe N, Frølund N, Seier S, Rønbøg JW, Nordsborg NB, Ebdrup BH. Exercise training complementary to specialised early intervention in patients with first-episode psychosis: a feasibility randomised trial. Pilot Feasibility Stud 2021;7:162. [PMID: 34412705 DOI: 10.1186/s40814-021-00900-5] [Reference Citation Analysis]
14 Bak M, Drukker M, Cortenraad S, Vandenberk E, Guloksuz S. Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis. PLoS One 2021;16:e0244944. [PMID: 33596211 DOI: 10.1371/journal.pone.0244944] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
15 Dobber J, Harmsen J, van Iersel M. Verdiepingsteksten. Klinisch redeneren en evidence-based practice 2021. [DOI: 10.1007/978-90-368-2610-5_12] [Reference Citation Analysis]
16 Romain AJ, Bernard P, Piché F, Kern L, Ouellet-plamondon C, Abdel-baki A, Roy M. Mens sana in corpore sano : l’intérêt de l’activité physique auprès des jeunes ayant eu un premier épisode psychotique. Santé mentale au Québec 2021;46:249. [DOI: 10.7202/1088185ar] [Reference Citation Analysis]
17 Smith J, Griffiths LA, Band M, Horne D. Cardiometabolic Risk in First Episode Psychosis Patients. Front Endocrinol (Lausanne) 2020;11:564240. [PMID: 33329382 DOI: 10.3389/fendo.2020.564240] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
18 Hardy S. Improving physical health in people with severe mental illness. Practice Nursing 2020;31:456-460. [DOI: 10.12968/pnur.2020.31.11.456] [Reference Citation Analysis]
19 Hasan A, Falkai P, Lehmann I, Gaebel W. Schizophrenia. Dtsch Arztebl Int 2020;117:412-9. [PMID: 32865492 DOI: 10.3238/arztebl.2020.0412] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
20 Gühne U, Weinmann S, Riedel-Heller SG, Becker T. Psychosocial therapies in severe mental illness: update on evidence and recommendations. Curr Opin Psychiatry 2020;33:414-21. [PMID: 32427593 DOI: 10.1097/YCO.0000000000000618] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
21 Schneider M, Pauwels P, Toto S, Bleich S, Grohmann R, Heinze M, Greiner T. Severe weight gain as an adverse drug reaction of psychotropics: Data from the AMSP project between 2001 and 2016. Eur Neuropsychopharmacol 2020;36:60-71. [PMID: 32536570 DOI: 10.1016/j.euroneuro.2020.05.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
22 Rossimel E, Teasdale SB, Poole J, Fibbins H, Curtis J, Watkins A, Rosenbaum S, Ward PB. Keeping our staff in mind: Dietary results of a lifestyle intervention targeting mental health staff. Health Promot J Austr 2021;32:451-7. [PMID: 32589312 DOI: 10.1002/hpja.377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Keks N, Hope J, Schwartz D, McLennan H, Copolov D, Meadows G. Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia. CNS Drugs 2020;34:473-507. [PMID: 32246399 DOI: 10.1007/s40263-020-00718-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
24 Campion J, Bhui K, Bhugra D. European Psychiatric Association (EPA) guidance on prevention of mental disorders. Eur psychiatr 2012;27:68-80. [DOI: 10.1016/j.eurpsy.2011.10.004] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 22.0] [Reference Citation Analysis]
25 Theleritis C, Bonaccorso S, Habib N, Stahl D, Gaughran F, Vitoratou S, Atakan Z, Kolliakou A, Gardner Sood P, Dazzan P, Marques T, Mcguire P, Greenwood K, Eberhard J, Breedvelt J, Ferracuti S, Di Forti M, Murray R, Smith S. Sexual dysfunction and central obesity in patients with first episode psychosis. Eur psychiatr 2017;42:1-7. [DOI: 10.1016/j.eurpsy.2016.11.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
26 Lee K, Choi HS, Han M. Effects of therapeutic lifestyle change mentoring on cardio-metabolic factors for schizophrenia. Arch Psychiatr Nurs 2020;34:19-26. [PMID: 32035584 DOI: 10.1016/j.apnu.2019.12.006] [Reference Citation Analysis]
27 Aran G, Hicks C, Demand A, Johnson AL, Beaman J, Bailey Y, Haught M, Lane A, Sinnett P, Vassar M. Treating schizophrenia: the quality of evidence behind treatment recommendations and how it can improve. BMJ Evid Based Med 2020;25:138-42. [PMID: 31672699 DOI: 10.1136/bmjebm-2019-111233] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
28 Nyboe L, Lemcke S, Møller AV, Stubbs B. Non-pharmacological interventions for preventing weight gain in patients with first episode schizophrenia or bipolar disorder: A systematic review. Psychiatry Res 2019;281:112556. [PMID: 31521840 DOI: 10.1016/j.psychres.2019.112556] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
29 Mucheru D, Hanlon M, Mcevoy M, Thakkinstian A, Macdonald-wicks L. Comparative efficacy of lifestyle intervention strategies targeting weight outcomes in people with psychosis: a systematic review and network meta-analysis. JBI Database of Systematic Reviews and Implementation Reports 2019;17:1770-825. [DOI: 10.11124/jbisrir-2017-003943] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
30 Kuppili PP, Nebhinani N. Role of Integrated and Multidisciplinary Approach in Combating Metabolic Syndrome in Patients with Severe Mental Illness. Indian J Psychol Med 2019;41:466-71. [PMID: 31548771 DOI: 10.4103/IJPSYM.IJPSYM_48_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
31 Wharton S, Kuk JL, Petrova L, Rye PI, Taylor VH, Christensen RAG. Effectiveness of a Community-Based Weight Management Program for Patients Taking Antidepressants and/or Antipsychotics. Obesity (Silver Spring) 2019;27:1539-44. [PMID: 31441235 DOI: 10.1002/oby.22567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Wilkinson S, Harvey W, Tabbane K. Leisure education and active participation for persons with schizophrenia and schizoaffective disorder. Leisure/Loisir 2019;43:315-37. [DOI: 10.1080/14927713.2019.1629828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Holt RI, Hind D, Gossage-Worrall R, Bradburn MJ, Saxon D, McCrone P, Morris TA, Etherington A, Shiers D, Barnard K, Swaby L, Edwardson C, Carey ME, Davies MJ, Dickens CM, Doherty Y, French P, Greenwood KE, Kalidindi S, Khunti K, Laugharne R, Pendlebury J, Rathod S, Siddiqi N, Wright S, Waller G, Gaughran F, Barnett J, Northern A. Structured lifestyle education to support weight loss for people with schizophrenia, schizoaffective disorder and first episode psychosis: the STEPWISE RCT. Health Technol Assess 2018;22:1-160. [PMID: 30499443 DOI: 10.3310/hta22650] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
34 Ayodele D, Oates J. Effectiveness of interventions to support weight loss in adults taking antipsychotics: a review. British Journal of Mental Health Nursing 2019;8:88-100. [DOI: 10.12968/bjmh.2019.8.2.88] [Reference Citation Analysis]
35 Osborn D, Burton A, Walters K, Atkins L, Barnes T, Blackburn R, Craig T, Gilbert H, Gray B, Hardoon S, Heinkel S, Holt R, Hunter R, Johnston C, King M, Leibowitz J, Marston L, Michie S, Morris R, Morris S, Nazareth I, Omar R, Petersen I, Peveler R, Pinfold V, Stevenson F, Zomer E. Primary care management of cardiovascular risk for people with severe mental illnesses: the Primrose research programme including cluster RCT. Programme Grants Appl Res 2019;7:1-98. [DOI: 10.3310/pgfar07020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Czosnek L, Lederman O, Cormie P, Zopf E, Stubbs B, Rosenbaum S. Health benefits, safety and cost of physical activity interventions for mental health conditions: A meta-review to inform translation efforts. Mental Health and Physical Activity 2019;16:140-51. [DOI: 10.1016/j.mhpa.2018.11.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
37 Coates D, Wright L, Moore T, Pinnell S, Merillo C, Howe D. The psychiatric, psychosocial and physical health profile of young people with early psychosis: Data from an early psychosis intervention service. Child & Youth Services 2019;40:93-115. [DOI: 10.1080/0145935x.2018.1553613] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
38 Vancampfort D, Firth J, Correll CU, Solmi M, Siskind D, De Hert M, Carney R, Koyanagi A, Carvalho AF, Gaughran F, Stubbs B. The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry 2019;18:53-66. [PMID: 30600626 DOI: 10.1002/wps.20614] [Cited by in Crossref: 111] [Cited by in F6Publishing: 111] [Article Influence: 27.8] [Reference Citation Analysis]
39 Fulton E, Peet M, Williamson K. More Harm than Good? A Pilot of a Motivational Interviewing Based Intervention for Increasing Readiness to Improve Nutrition in Young People Experiencing a First Episode of Psychosis. HPB 2019;3:1. [DOI: 10.5334/hpb.10] [Reference Citation Analysis]
40 Higdon C, Eichenbaum RM, Delbello MP. Pragmatic Trials: Solving the Dilemma of Psychiatric Nonadherence. Psychiatric Nonadherence 2019. [DOI: 10.1007/978-3-030-12665-0_13] [Reference Citation Analysis]
41 Skonieczna-Żydecka K, Łoniewski I, Misera A, Stachowska E, Maciejewska D, Marlicz W, Galling B. Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome. Psychopharmacology (Berl) 2019;236:1491-512. [PMID: 30460516 DOI: 10.1007/s00213-018-5102-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 13.0] [Reference Citation Analysis]
42 Gaebel W, Hasan A, Falkai P. Pharmakotherapie und andere somatische Behandlungsverfahren (Modul 4a). S3-Leitlinie Schizophrenie 2019. [DOI: 10.1007/978-3-662-59380-6_5] [Reference Citation Analysis]
43 Morrison AP. Should people with psychosis be supported in choosing cognitive therapy as an alternative to antipsychotic medication: A commentary on current evidence. Schizophr Res 2019;203:94-8. [PMID: 29606545 DOI: 10.1016/j.schres.2018.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
44 Lee J. Metabolic Side Effects of Antipsychotic Medication: An Overview. J Korean Neuropsychiatr Assoc 2019;58:18. [DOI: 10.4306/jknpa.2019.58.1.18] [Reference Citation Analysis]
45 Al-sayed HM, Soliman WI. Potential Toxic Effects of Olanzapine on Metabolic Parameters in <i>de Novo</i> Paranoid Schizophrenic Patients. The Role of Adjunctive Aripeprazole: Clinical and Experimental Study. ODEM 2019;07:91-113. [DOI: 10.4236/odem.2019.73008] [Reference Citation Analysis]
46 Addington D, Birchwood M, Jones P, Killackey E, McDaid D, Melau M, Mizuno M, Mueser K, Nordentoft M. Fidelity scales and performance measures to support implementation and quality assurance for first episode psychosis services. Early Interv Psychiatry 2018;12:1235-42. [PMID: 29882236 DOI: 10.1111/eip.12684] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
47 Singh VK, Karmani S, Malo PK, Virupaksha HG, Muralidhar D, Venkatasubramanian G, Muralidharan K. Impact of lifestyle modification on some components of metabolic syndrome in persons with severe mental disorders: A meta-analysis. Schizophr Res 2018;202:17-25. [PMID: 30539768 DOI: 10.1016/j.schres.2018.06.066] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
48 Zhuo C, Xu Y, Liu S, Li J, Zheng Q, Gao X, Li S, Jing R, Song X, Yue W, Zhou C, Upthegrove R. Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis. Front Pharmacol 2018;9:1393. [PMID: 30546312 DOI: 10.3389/fphar.2018.01393] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
49 Wharton S, Raiber L, Serodio KJ, Lee J, Christensen RA. Medications that cause weight gain and alternatives in Canada: a narrative review. Diabetes Metab Syndr Obes 2018;11:427-38. [PMID: 30174450 DOI: 10.2147/DMSO.S171365] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
50 Grootens KP, Meijer A, Hartong EG, Doornbos B, Bakker PR, Al Hadithy A, Hoogerheide KN, Overmeire F, Marijnissen RM, Ruhe HG. Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder. Eur J Clin Pharmacol 2018;74:1485-9. [PMID: 30083876 DOI: 10.1007/s00228-018-2517-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
51 Firth J, Carney R, French P, Elliott R, Cotter J, Yung AR. Long-term maintenance and effects of exercise in early psychosis. Early Interv Psychiatry 2018;12:578-85. [PMID: 27587302 DOI: 10.1111/eip.12365] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
52 Gurusamy J, Gandhi S, Damodharan D, Ganesan V, Palaniappan M. Exercise, diet and educational interventions for metabolic syndrome in persons with schizophrenia: A systematic review. Asian J Psychiatr 2018;36:73-85. [PMID: 29990631 DOI: 10.1016/j.ajp.2018.06.018] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
53 Woodhead G, Hitch D, Bolton K, Albiston D, Killackey E. Pilot study of client outcomes from exercise physiology in a youth mental health service. Early Interv Psychiatry 2018;12:734-9. [PMID: 28509390 DOI: 10.1111/eip.12436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
54 Romain AJ. An ounce of prevention outweighs kilograms of weight loss. Psychiatry Res 2018;262:341-2. [PMID: 28602474 DOI: 10.1016/j.psychres.2017.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
55 Bonfioli E, Mazzi MA, Berti L, Burti L. Physical health promotion in patients with functional psychoses receiving community psychiatric services: Results of the PHYSICO-DSM-VR study. Schizophr Res 2018;193:406-11. [PMID: 28709772 DOI: 10.1016/j.schres.2017.06.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
56 McBain H, Lamontagne-Godwin F, Haddad M, Simpson A, Chapman J, Jones J, Flood C, Mulligan K. Management of type 2 diabetes mellitus in people with severe mental illness: an online cross-sectional survey of healthcare professionals. BMJ Open 2018;8:e019400. [PMID: 29449295 DOI: 10.1136/bmjopen-2017-019400] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
57 Mitchell AJ, Delaffon V, Lord O. Let's get physical: improving the medical care of people with severe mental illness. Adv psychiatr treat 2012;18:216-25. [DOI: 10.1192/apt.bp.111.009068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
58 James AC. Prescribing antipsychotics for children and adolescents. Adv psychiatr treat 2010;16:63-75. [DOI: 10.1192/apt.bp.108.005652] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
59 Bailey S, Gerada C, Lester H, Shiers D. The cardiovascular health of young people with severe mental illness: addressing an epidemic within an epidemic. Psychiatrist 2012;36:375-8. [DOI: 10.1192/pb.bp.112.039727] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
60 Mccabe E, Parrish M. A review of the complexities of working effectively with people being prescribed both antipsychotic medications and opioid substitution therapy. Drugs: Education, Prevention and Policy 2018;25:1-12. [DOI: 10.1080/09687637.2016.1277983] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
61 Gluth A, White D, Ward M. Lifestyle Interventions in Patients With Serious Mental Illness. Lifestyle in Heart Health and Disease 2018. [DOI: 10.1016/b978-0-12-811279-3.00020-3] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
62 Kang D, Jing Z, Li R, Hei G, Shao T, Li L, Sun M, Yang Y, Wang Y, Wang X, Long Y, Huang X, Wu R. Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials. Front Psychiatry 2018;9:620. [PMID: 30542300 DOI: 10.3389/fpsyt.2018.00620] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
63 Santesteban-echarri O, Paino M, Rice S, González-blanch C, Mcgorry P, Gleeson J, Alvarez-jimenez M. Predictors of functional recovery in first-episode psychosis: A systematic review and meta-analysis of longitudinal studies. Clinical Psychology Review 2017;58:59-75. [DOI: 10.1016/j.cpr.2017.09.007] [Cited by in Crossref: 133] [Cited by in F6Publishing: 138] [Article Influence: 22.2] [Reference Citation Analysis]
64 Suarez CA, Annunziata AI, Dwyer JT. Nutrition for Persons Coping With Serious Mental Illnesses. Nutr Today 2017;52:190-202. [DOI: 10.1097/nt.0000000000000223] [Reference Citation Analysis]
65 Naslund JA, Whiteman KL, McHugo GJ, Aschbrenner KA, Marsch LA, Bartels SJ. Lifestyle interventions for weight loss among overweight and obese adults with serious mental illness: A systematic review and meta-analysis. Gen Hosp Psychiatry 2017;47:83-102. [PMID: 28807143 DOI: 10.1016/j.genhosppsych.2017.04.003] [Cited by in Crossref: 94] [Cited by in F6Publishing: 94] [Article Influence: 15.7] [Reference Citation Analysis]
66 Verhaegen AA, Van Gaal LF. Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options. J Endocrinol Invest 2017;40:1165-74. [PMID: 28660606 DOI: 10.1007/s40618-017-0719-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
67 Mucheru DW, Hanlon M, Mcevoy M, Macdonald-wicks L. Comparative efficacy of lifestyle intervention strategies on weight outcomes in people with psychosis: a systematic review and network meta-analysis protocol. JBI Database of Systematic Reviews and Implementation Reports 2017;15:1593-601. [DOI: 10.11124/jbisrir-2016-003121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
68 Hjorth P, Medici CR, Juel A, Madsen NJ, Vandborg K, Munk-Jørgensen P. Improving quality of life and physical health in patients with schizophrenia: A 30-month program carried out in a real-life setting. Int J Soc Psychiatry 2017;63:287-96. [PMID: 28367717 DOI: 10.1177/0020764017702172] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
69 Teasdale SB, Samaras K, Wade T, Jarman R, Ward PB. A review of the nutritional challenges experienced by people living with severe mental illness: a role for dietitians in addressing physical health gaps. J Hum Nutr Diet. 2017;30:545-553. [PMID: 28419586 DOI: 10.1111/jhn.12473] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
70 Hayashi Y, Rivera EA, Modico JG, Foreman AM, Wirth O. Texting while driving, executive function, and impulsivity in college students. Accid Anal Prev 2017;102:72-80. [PMID: 28267655 DOI: 10.1016/j.aap.2017.02.016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
71 Bersani FS, Biondi M, Coviello M, Fagiolini A, Majorana M, Minichino A, Rusconi AC, Vergnani L, Vicinanza R, Coccanari De' Fornari MA. Psychoeducational intervention focused on healthy living improves psychopathological severity and lifestyle quality in psychiatric patients: preliminary findings from a controlled study. J Ment Health 2017;26:271-5. [PMID: 28558488 DOI: 10.1080/09638237.2017.1294741] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
72 Kim YS, Song BK, Lee O, Kwon HJ. Comparison of Segmental Colon Transit Time With Total Energy Expenditure in Psychiatry Unit Patients. Gastroenterol Nurs 2015;38:440-5. [PMID: 25181498 DOI: 10.1097/SGA.0000000000000061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
73 Teasdale SB, Ward PB, Rosenbaum S, Samaras K, Stubbs B. Solving a weighty problem: systematic review and meta-analysis of nutrition interventions in severe mental illness. Br J Psychiatry 2017;210:110-8. [PMID: 27810893 DOI: 10.1192/bjp.bp.115.177139] [Cited by in Crossref: 123] [Cited by in F6Publishing: 121] [Article Influence: 20.5] [Reference Citation Analysis]
74 Dayabandara M, Hanwella R, Ratnatunga S, Seneviratne S, Suraweera C, de Silva VA. Antipsychotic-associated weight gain: management strategies and impact on treatment adherence. Neuropsychiatr Dis Treat 2017;13:2231-41. [PMID: 28883731 DOI: 10.2147/NDT.S113099] [Cited by in Crossref: 144] [Cited by in F6Publishing: 140] [Article Influence: 24.0] [Reference Citation Analysis]
75 Mills C, White RG. ‘Global Mental Health Spreads Like Bush Fire in the Global South’: Efforts to Scale Up Mental Health Services in Low- and Middle-Income Countries. The Palgrave Handbook of Sociocultural Perspectives on Global Mental Health 2017. [DOI: 10.1057/978-1-137-39510-8_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
76 Jain S, Andridge R, Hellings JA. Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review. J Autism Dev Disord 2016;46:1344-53. [PMID: 26687568 DOI: 10.1007/s10803-015-2675-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
77 Haddad M, Llewellyn-Jones S, Yarnold S, Simpson A. Improving the physical health of people with severe mental illness in a low secure forensic unit: An uncontrolled evaluation study of staff training and physical health care plans. Int J Ment Health Nurs 2016;25:554-65. [PMID: 27443217 DOI: 10.1111/inm.12246] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
78 Detke HC, DelBello MP, Landry J, Hoffmann VP, Heinloth A, Dittmann RW. A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder. J Child Adolesc Psychopharmacol 2016;26:922-34. [PMID: 27676420 DOI: 10.1089/cap.2016.0010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
79 Cheng JF, Huang XY, Liu TL, Wang RY, Ching HY. The Relationship between Body Weight Change and Body Constitutions of Traditional Chinese Medicine in Patients with Schizophrenia. Evid Based Complement Alternat Med 2016;2016:9585968. [PMID: 27818703 DOI: 10.1155/2016/9585968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
80 de Silva VA, Suraweera C, Ratnatunga SS, Dayabandara M, Wanniarachchi N, Hanwella R. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. BMC Psychiatry 2016;16:341. [PMID: 27716110 DOI: 10.1186/s12888-016-1049-5] [Cited by in Crossref: 102] [Cited by in F6Publishing: 103] [Article Influence: 14.6] [Reference Citation Analysis]
81 Citrome L, McEvoy JP, Saklad SR. A Guide to the Management of Clozapine-Related Tolerability and Safety Concerns. Clin Schizophr Relat Psychoses. 2016;. [PMID: 27454214 DOI: 10.3371/csrp.saci.070816] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
82 McBain H, Mulligan K, Lamontagne-Godwin F, Jones J, Haddad M, Flood C, Thomas D, Simpson A. Implementation of recommended type 2 diabetes care for people with severe mental illness - a qualitative exploration with healthcare professionals. BMC Psychiatry 2016;16:222. [PMID: 27391590 DOI: 10.1186/s12888-016-0942-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
83 D'avanzo B, Parabiaghi A. Conoscenze e cultura dell'uso degli psicofarmaci: che cosa si deposita nelle strategie di utilizzo degli psicofarmaci nei servizi di salute mentale? RIVISTA SPERIMENTALE DI FRENIATRIA 2016. [DOI: 10.3280/rsf2016-002002] [Reference Citation Analysis]
84 Wei Xin Chong J, Hsien-Jie Tan E, Chong CE, Ng Y, Wijesinghe R. Atypical antipsychotics: A review on the prevalence, monitoring, and management of their metabolic and cardiovascular side effects. Ment Health Clin 2016;6:178-84. [PMID: 29955467 DOI: 10.9740/mhc.2016.07.178] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
85 Jones J, McBain H, Lamontagne-Godwin F, Mulligan K, Haddad M, Flood C, Thomas D, Simpson A. Severe mental illness and type 2 diabetes: using theory and research evidence to develop complex behaviour change interventions. J Psychiatr Ment Health Nurs 2016;23:312-21. [PMID: 27307262 DOI: 10.1111/jpm.12311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
86 Curtis J, Watkins A, Rosenbaum S, Teasdale S, Kalucy M, Samaras K, Ward PB. Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic-induced weight gain in first-episode psychosis. Early Interv Psychiatry 2016;10:267-76. [PMID: 25721464 DOI: 10.1111/eip.12230] [Cited by in Crossref: 149] [Cited by in F6Publishing: 156] [Article Influence: 21.3] [Reference Citation Analysis]
87 Teasdale SB, Ward PB, Rosenbaum S, Watkins A, Curtis J, Kalucy M, Samaras K. A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis. Br J Nutr 2016;115:1987-93. [DOI: 10.1017/s0007114516001033] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
88 Rado J, von Ammon Cavanaugh S. A Naturalistic Randomized Placebo-Controlled Trial of Extended-Release Metformin to Prevent Weight Gain Associated With Olanzapine in a US Community-Dwelling Population. J Clin Psychopharmacol 2016;36:163-8. [PMID: 26872112 DOI: 10.1097/JCP.0000000000000469] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
89 Baxter AJ, Harris MG, Khatib Y, Brugha TS, Bien H, Bhui K. Reducing excess mortality due to chronic disease in people with severe mental illness: meta-review of health interventions. Br J Psychiatry 2016;208:322-9. [PMID: 26941263 DOI: 10.1192/bjp.bp.115.163170] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
90 Weinstein LC, Stefancic A, Cunningham AT, Hurley KE, Cabassa LJ, Wender RC. Cancer screening, prevention, and treatment in people with mental illness. CA Cancer J Clin 2016;66:134-51. [PMID: 26663383 DOI: 10.3322/caac.21334] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 6.9] [Reference Citation Analysis]
91 Provencher MD, Bélanger MÈ, Shriqui C, Lachance I, Bonneville S. [Psychoeducation for overweight patients with psychiatric disorders: The Wellness program developed in Quebec]. Encephale 2016;42:201-7. [PMID: 26924000 DOI: 10.1016/j.encep.2016.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
92 McGinty EE, Baller J, Azrin ST, Juliano-Bult D, Daumit GL. Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review. Schizophr Bull 2016;42:96-124. [PMID: 26221050 DOI: 10.1093/schbul/sbv101] [Cited by in Crossref: 28] [Cited by in F6Publishing: 61] [Article Influence: 4.0] [Reference Citation Analysis]
93 Wärdig RE, Foldemo A, Hultsjö S, Lindström T, Bachrach-Lindström M. An Intervention with Physical Activity and Lifestyle Counseling Improves Health-Related Quality of Life and Shows Small Improvements in Metabolic Risks in Persons with Psychosis. Issues Ment Health Nurs 2016;37:43-52. [PMID: 26818932 DOI: 10.3109/01612840.2015.1092187] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
94 Chalfoun C, Karelis AD, Stip E, Abdel-Baki A. Running for your life: A review of physical activity and cardiovascular disease risk reduction in individuals with schizophrenia. J Sports Sci 2016;34:1500-15. [PMID: 26630458 DOI: 10.1080/02640414.2015.1119875] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
95 de Silva VA, Dayabandara M, Wijesundara H, Henegama T, Gunewardena H, Suraweera C, Hanwella R. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study. J Psychopharmacol 2015;29:1255-61. [PMID: 26510448 DOI: 10.1177/0269881115613519] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
96 Richards L, Batscha CL, McCarthy VL. Lifestyle and Behavioral Interventions to Reduce the Risk of Metabolic Syndrome in Community-Dwelling Adults With Serious Mental Illness: Implications for Nursing Practice. J Psychosoc Nurs Ment Health Serv 2016;54:46-55. [PMID: 26565415 DOI: 10.3928/02793695-20151109-02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
97 Hardy SA. The perplexing issue of severe mental illness, physical health screening and primary care in England. J Psychiatr Ment Health Nurs 2015;22:647-52. [PMID: 26337596 DOI: 10.1111/jpm.12236] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
98 Gross J, Vancampfort D, Stubbs B, Gorczynski P, Soundy A. A narrative synthesis investigating the use and value of social support to promote physical activity among individuals with schizophrenia. Disabil Rehabil 2016;38:123-50. [PMID: 25786476 DOI: 10.3109/09638288.2015.1024343] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
99 Cabassa LJ, Stefancic A, O'Hara K, El-Bassel N, Lewis-Fernández R, Luchsinger JA, Gates L, Younge R, Wall M, Weinstein L, Palinkas LA. Peer-led healthy lifestyle program in supportive housing: study protocol for a randomized controlled trial. Trials 2015;16:388. [PMID: 26329472 DOI: 10.1186/s13063-015-0902-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
100 Niv N, Cohen AN, Hamilton A, Reist C, Young AS. Effectiveness of a psychosocial weight management program for individuals with schizophrenia. J Behav Health Serv Res 2014;41:370-80. [PMID: 22430566 DOI: 10.1007/s11414-012-9273-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
101 Gates J, Killackey E, Phillips L, Álvarez-Jiménez M. Mental health starts with physical health: current status and future directions of non-pharmacological interventions to improve physical health in first-episode psychosis. Lancet Psychiatry 2015;2:726-42. [PMID: 26249304 DOI: 10.1016/S2215-0366(15)00213-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
102 Deighton S, Addington J. Exercise practices in individuals at clinical high risk of developing psychosis. Early Interv Psychiatry 2015;9:284-91. [PMID: 24252093 DOI: 10.1111/eip.12107] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
103 Eskelinen S, Sailas E, Joutsenniemi K, Holi M, Suvisaari J. Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia. Nord J Psychiatry 2015;69:339-45. [PMID: 25981178 DOI: 10.3109/08039488.2014.983544] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
104 Firth J, Cotter J, Elliott R, French P, Yung AR. A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychol Med 2015;45:1343-61. [PMID: 25650668 DOI: 10.1017/S0033291714003110] [Cited by in Crossref: 355] [Cited by in F6Publishing: 348] [Article Influence: 44.4] [Reference Citation Analysis]
105 Marshall M, Barrowclough C, Drake R, Husain N, Lobban F, Lovell K, Wearden A, Bradshaw T, Day C, Fitzsimmons M, Pedley R, Piccuci R, Picken A, Larkin W, Tomenson B, Warburton J, Gregg L. The HELPER programme: HEalthy Living and Prevention of Early Relapse – three exploratory randomised controlled trials of phase-specific interventions in first-episode psychosis. Programme Grants for Applied Research 2015;3:1-238. [DOI: 10.3310/pgfar03020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
106 Bartels SJ, Pratt SI, Aschbrenner KA, Barre LK, Naslund JA, Wolfe R, Xie H, McHugo GJ, Jimenez DE, Jue K, Feldman J, Bird BL. Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes. Am J Psychiatry 2015;172:344-52. [PMID: 25827032 DOI: 10.1176/appi.ajp.2014.14030357] [Cited by in Crossref: 110] [Cited by in F6Publishing: 116] [Article Influence: 13.8] [Reference Citation Analysis]
107 Kemp V, Fisher C, Lawn S, Battersby M, Isaac MK. Small steps: physical health promotion for people living with mental illness. International Journal of Mental Health Promotion 2015;17:97-112. [DOI: 10.1080/14623730.2015.1010370] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
108 Whitney Z, Procyshyn RM, Fredrikson DH, Barr AM. Treatment of clozapine-associated weight gain: a systematic review. Eur J Clin Pharmacol 2015;71:389-401. [PMID: 25627831 DOI: 10.1007/s00228-015-1807-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
109 Ronsley R, Chow L, Kuss K, Davidson J, Panagiotopoulos C. Ensuring the Safety of Children Treated with Second-Generation Antipsychotics. The Science and Ethics of Antipsychotic Use in Children 2015. [DOI: 10.1016/b978-0-12-800016-8.00004-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
110 Soundy A, Muhamed A, Stubbs B, Probst M, Vancampfort D. The benefits of walking for individuals with schizophrenia spectrum disorders: A systematic review. International Journal of Therapy and Rehabilitation 2014;21:410-20. [DOI: 10.12968/ijtr.2014.21.9.410] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
111 Kim YS, Song BK, Oh JS, Woo SS. Aerobic exercise improves gastrointestinal motility in psychiatric inpatients. World J Gastroenterol 2014; 20(30): 10577-10584 [PMID: 25132778 DOI: 10.3748/wjg.v20.i30.10577] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
112 Graham C, Rollings C, de Leeuw S, Anderson L, Griffiths B, Long N. A qualitative study exploring facilitators for improved health behaviors and health behavior programs: mental health service users' perspectives. ScientificWorldJournal 2014;2014:870497. [PMID: 24895667 DOI: 10.1155/2014/870497] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
113 Bak M, Fransen A, Janssen J, van Os J, Drukker M. Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One 2014;9:e94112. [PMID: 24763306 DOI: 10.1371/journal.pone.0094112] [Cited by in Crossref: 286] [Cited by in F6Publishing: 312] [Article Influence: 31.8] [Reference Citation Analysis]
114 Morrison AP, Turkington D, Pyle M, Spencer H, Brabban A, Dunn G, Christodoulides T, Dudley R, Chapman N, Callcott P, Grace T, Lumley V, Drage L, Tully S, Irving K, Cummings A, Byrne R, Davies LM, Hutton P. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Lancet 2014;383:1395-403. [PMID: 24508320 DOI: 10.1016/S0140-6736(13)62246-1] [Cited by in Crossref: 162] [Cited by in F6Publishing: 123] [Article Influence: 18.0] [Reference Citation Analysis]
115 Bradshaw T, Mairs H. Obesity and Serious Mental Ill Health: A Critical Review of the Literature. Healthcare (Basel) 2014;2:166-82. [PMID: 27429268 DOI: 10.3390/healthcare2020166] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
116 Cordes J, Thünker J, Regenbrecht G, Zielasek J, Correll CU, Schmidt-Kraepelin C, Lange-Asschenfeldt C, Agelink MW, Kahl KG, Gaebel W, Klimke A, Hauner H. Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial. World J Biol Psychiatry 2014;15:229-41. [PMID: 21745127 DOI: 10.3109/15622975.2011.592546] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
117 Vancampfort D, Knapen J, De Hert M, van Winkel R, Deckx S, Maurissen K, Peuskens J, Simons J, Probst M. Cardiometabolic effects of physical activity interventions for people with schizophrenia. Physical Therapy Reviews 2013;14:388-98. [DOI: 10.1179/108331909x12540993898053] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
118 Arenas Borrero ÁE, Gómez Restrepo C, Bohórquez Peñaranda AP, Vélez Traslaviña Á, Castro Díaz SM, Jaramillo González LE, García Valencia J. Prevención y tratamiento de los efectos adversos agudos más frecuentes por el uso de antipsicóticos en pacientes adultos con diagnóstico de esquizofrenia. Revista Colombiana de Psiquiatría 2014;44:66-74. [DOI: 10.1016/j.rcp.2015.05.009] [Reference Citation Analysis]
119 Atsariyasing W, Goldman M. Management of Medication-Related Adverse Effects. Schizophrenia 2014. [DOI: 10.1007/978-1-4939-0656-7_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
120 Rado JT. Management of Comorbid Medical Conditions in Schizophrenia. Schizophrenia 2014. [DOI: 10.1007/978-1-4939-0656-7_10] [Reference Citation Analysis]
121 Fernández-San-Martín MI, Martín-López LM, Masa-Font R, Olona-Tabueña N, Roman Y, Martin-Royo J, Oller-Canet S, González-Tejón S, San-Emeterio L, Barroso-Garcia A, Viñas-Cabrera L, Flores-Mateo G. The effectiveness of lifestyle interventions to reduce cardiovascular risk in patients with severe mental disorders: meta-analysis of intervention studies. Community Ment Health J 2014;50:81-95. [PMID: 23739948 DOI: 10.1007/s10597-013-9614-6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
122 Nover C, Jackson SS. Primary care-based educational interventions to decrease risk factors for metabolic syndrome for adults with major psychotic and/or affective disorders: a systematic review. Syst Rev 2013;2:116. [PMID: 24369749 DOI: 10.1186/2046-4053-2-116] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
123 Lester H. The James Mackenzie Lecture 2012: bothering about Billy. Br J Gen Pract 2013;63:e232-4. [PMID: 23561791 DOI: 10.3399/bjgp13X664414] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
124 Cunningham C, Peters K, Mannix J. Physical health inequities in people with severe mental illness: identifying initiatives for practice change. Issues Ment Health Nurs 2013;34:855-62. [PMID: 24274241 DOI: 10.3109/01612840.2013.832826] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
125 Kerling A, Tegtbur U, Ziegenbein M, Grams L, Heinze DR, Sieberer M. Exercise capacity and quality of life in patients with schizophrenia. Psychiatr Q 2013;84:417-27. [PMID: 23456450 DOI: 10.1007/s11126-013-9256-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
126 Murphy AL, Gardner DM, Kisely S, Cooke C, Kutcher SP, Hughes J. Youth, caregiver, and prescriber experiences of antipsychotic-related weight gain. ISRN Obes 2013;2013:390130. [PMID: 24533223 DOI: 10.1155/2013/390130] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
127 Bélanger M, Provencher MD, Shriqui C. Efficacité des programmes de modifications des habitudes de vie pour la gestion de poids des personnes avec des troubles psychiatriques. smq 2013;38:103-18. [DOI: 10.7202/1019188ar] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
128 Schneider KL, Sullivan JC, Pagoto SL. Translation of the diabetes prevention program into a community mental health organization for individuals with severe mental illness: a case study. Transl Behav Med 2011;1:453-60. [PMID: 24073066 DOI: 10.1007/s13142-011-0053-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
129 Hultsjö S, Blomqvist KB. Health behaviors as conceptualized by individuals diagnosed with a psychotic disorder. Issues Ment Health Nurs 2013;34:665-72. [PMID: 24004360 DOI: 10.3109/01612840.2013.794178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
130 McNamee L, Mead G, MacGillivray S, Lawrie SM. Schizophrenia, poor physical health and physical activity: evidence-based interventions are required to reduce major health inequalities. Br J Psychiatry 2013;203:239-41. [PMID: 24085733 DOI: 10.1192/bjp.bp.112.125070] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
131 Bartels SJ, Pratt SI, Aschbrenner KA, Barre LK, Jue K, Wolfe RS, Xie H, McHugo G, Santos M, Williams GE, Naslund JA, Mueser KT. Clinically significant improved fitness and weight loss among overweight persons with serious mental illness. Psychiatr Serv 2013;64:729-36. [PMID: 23677386 DOI: 10.1176/appi.ps.003622012] [Cited by in Crossref: 122] [Cited by in F6Publishing: 131] [Article Influence: 12.2] [Reference Citation Analysis]
132 Rado JT, Keim KS, Dowd SM. Management of Antipsychotic-Induced Weight Gain: Part II. Psychopharm Review 2013;48:49-56. [DOI: 10.1097/01.psyphr.0000431986.53973.d8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
133 Taylor J, Cottrell C, Chatterton H, Hill J, Hughes R, Wohlgemuth C, Holt RI. Identifying risk and preventing progression to Type 2 diabetes in vulnerable and disadvantaged adults: a pragmatic review. Diabet Med 2013;30:16-25. [PMID: 23002995 DOI: 10.1111/dme.12027] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
134 Eapen V, Shiers D, Curtis J. Bridging the gap from evidence to policy and practice: reducing the progression to metabolic syndrome for children and adolescents on antipsychotic medication. Aust N Z J Psychiatry 2013;47:435-42. [PMID: 23047958 DOI: 10.1177/0004867412463169] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
135 Roberts SH, Bailey JE. An ethnographic study of the incentives and barriers to lifestyle interventions for people with severe mental illness. J Adv Nurs 2013;69:2514-24. [DOI: 10.1111/jan.12136] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
136 Attux C, Martini LC, Elkis H, Tamai S, Freirias A, Camargo Md, Mateus MD, Mari Jde J, Reis AF, Bressan RA. A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia. BMC Psychiatry 2013;13:60. [PMID: 23418863 DOI: 10.1186/1471-244X-13-60] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
137 Nyboe L, Lund H. Low levels of physical activity in patients with severe mental illness. Nord J Psychiatry 2013;67:43-6. [PMID: 22563711 DOI: 10.3109/08039488.2012.675588] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 5.4] [Reference Citation Analysis]
138 Morrison AP, Wardle M, Hutton P, Davies L, Dunn G, Brabban A, Byrne R, Drage L, Spencer H, Turkington D. Assessing Cognitive Therapy Instead Of Neuroleptics: Rationale, study design and sample characteristics of the ACTION trial. Psychosis 2013;5:82-92. [DOI: 10.1080/17522439.2012.756539] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
139 Werneke U, Taylor D, Sanders TA. Behavioral interventions for antipsychotic induced appetite changes. Curr Psychiatry Rep 2013;15:347. [PMID: 23404388 DOI: 10.1007/s11920-012-0347-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
140 Shean GD. Empirically Based Psychosocial Therapies for Schizophrenia: The Disconnection between Science and Practice. Schizophr Res Treatment 2013;2013:792769. [PMID: 23738068 DOI: 10.1155/2013/792769] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
141 McElroy SL, Keck PE Jr. Obesity in bipolar disorder: an overview. Curr Psychiatry Rep 2012;14:650-8. [PMID: 22903246 DOI: 10.1007/s11920-012-0313-8] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 7.2] [Reference Citation Analysis]
142 Papanastasiou E. Interventions for the metabolic syndrome in schizophrenia: a review. Ther Adv Endocrinol Metab 2012;3:141-62. [PMID: 23185687 DOI: 10.1177/2042018812458697] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
143 Hasnain M, Vieweg WV, Hollett B. Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians. Postgrad Med 2012;124:154-67. [PMID: 22913904 DOI: 10.3810/pgm.2012.07.2577] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 5.8] [Reference Citation Analysis]
144 Caemmerer J, Correll CU, Maayan L. Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials. Schizophr Res 2012;140:159-68. [PMID: 22763424 DOI: 10.1016/j.schres.2012.03.017] [Cited by in Crossref: 126] [Cited by in F6Publishing: 129] [Article Influence: 11.5] [Reference Citation Analysis]
145 Baptista T. Cardiometabolic risk factors in people with psychotic disorders: the second Australian survey of psychosis: going back to the foundations. Aust N Z J Psychiatry 2012;46:901-3. [PMID: 22956568 DOI: 10.1177/0004867412457088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
146 Zhang JP, Weiss JJ, McCardle M, Klopchin H, Rosendahl E, Maayan L, Convit A, Kane JM, Manu P, Correll CU. Effectiveness of a cognitive behavioral weight management intervention in obese patients with psychotic disorders compared to patients with nonpsychotic disorders or no psychiatric disorders: results from a 12-month, real-world study. J Clin Psychopharmacol 2012;32:458-64. [PMID: 22722502 DOI: 10.1097/JCP.0b013e31825cccd2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
147 Curtis J, Newall HD, Samaras K. The heart of the matter: cardiometabolic care in youth with psychosis. Early Interv Psychiatry 2012;6:347-53. [PMID: 22221395 DOI: 10.1111/j.1751-7893.2011.00315.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 6.6] [Reference Citation Analysis]
148 Morrison AP, Hutton P, Shiers D, Turkington D. Antipsychotics: is it time to introduce patient choice? Br J Psychiatry 2012;201:83-4. [PMID: 22859572 DOI: 10.1192/bjp.bp.112.112110] [Cited by in Crossref: 90] [Cited by in F6Publishing: 92] [Article Influence: 8.2] [Reference Citation Analysis]
149 Carr VJ, Whiteford H, Groves A, McGorry P, Shepherd AM. Policy and service development implications of the second Australian National Survey of High Impact Psychosis (SHIP). Aust N Z J Psychiatry 2012;46:708-18. [PMID: 22563037 DOI: 10.1177/0004867412446488] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
150 Bonfioli E, Berti L, Goss C, Muraro F, Burti L. Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials. BMC Psychiatry 2012;12:78. [PMID: 22789023 DOI: 10.1186/1471-244X-12-78] [Cited by in Crossref: 101] [Cited by in F6Publishing: 105] [Article Influence: 9.2] [Reference Citation Analysis]
151 Bradshaw T, Pedley R. Evolving role of mental health nurses in the physical health care of people with serious mental health illness. Int J Ment Health Nurs 2012;21:266-73. [PMID: 22533334 DOI: 10.1111/j.1447-0349.2012.00818.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 6.0] [Reference Citation Analysis]
152 Beary M, Hodgson R, Wildgust HJ. A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications. J Psychopharmacol 2012;26:52-61. [PMID: 22465947 DOI: 10.1177/0269881112440512] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
153 Morrison AP, French P, Stewart SL, Birchwood M, Fowler D, Gumley AI, Jones PB, Bentall RP, Lewis SW, Murray GK, Patterson P, Brunet K, Conroy J, Parker S, Reilly T, Byrne R, Davies LM, Dunn G. Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ 2012;344:e2233. [PMID: 22491790 DOI: 10.1136/bmj.e2233] [Cited by in Crossref: 219] [Cited by in F6Publishing: 224] [Article Influence: 19.9] [Reference Citation Analysis]
154 Choong E, Bondolfi G, Etter M, Jermann F, Aubry JM, Bartolomei J, Gholam-Rezaee M, Eap CB. Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population. J Psychiatr Res 2012;46:540-8. [PMID: 22316639 DOI: 10.1016/j.jpsychires.2012.01.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
155 Chang S, Lu M. Metabolic and Cardiovascular Adverse Effects Associated with Treatment with Antipsychotic Drugs. Journal of Experimental & Clinical Medicine 2012;4:103-7. [DOI: 10.1016/j.jecm.2012.01.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
156 Bradshaw T, Wearden A, Marshall M, Warburton J, Husain N, Pedley R, Escott D, Swarbrick C, Lovell K. Developing a healthy living intervention for people with early psychosis using the Medical Research Council's guidelines on complex interventions: Phase 1 of the HELPER – InterACT programme. International Journal of Nursing Studies 2012;49:398-406. [DOI: 10.1016/j.ijnurstu.2011.10.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
157 Fiedorowicz JG, Miller DD, Bishop JR, Calarge CA, Ellingrod VL, Haynes WG. Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers. Curr Psychiatry Rev 2012;8:25-36. [PMID: 22712004 DOI: 10.2174/157340012798994867] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 4.1] [Reference Citation Analysis]
158 Gross CM, van Elst LT. Psychological and Psychiatric Contraindications. Principles of Metabolic Surgery 2012. [DOI: 10.1007/978-3-642-02411-5_13] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
159 Willmott M, Wolstencroft HA. Improving life expectancy in people with schizophrenia: Reducing drug-induced weight gain. bpscpf 2012;1:39-46. [DOI: 10.53841/bpscpf.2012.1.229.39] [Reference Citation Analysis]
160 Maayan L, Correll CU. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol 2011;21:517-35. [PMID: 22166172 DOI: 10.1089/cap.2011.0015] [Cited by in Crossref: 186] [Cited by in F6Publishing: 189] [Article Influence: 15.5] [Reference Citation Analysis]
161 Gillhoff K, Gaab J, Emini L, Maroni C, Tholuck J, Greil W. Effects of a multimodal lifestyle intervention on body mass index in patients with bipolar disorder: a randomized controlled trial. Prim Care Companion J Clin Psychiatry 2010;12:PCC. [PMID: 21274359 DOI: 10.4088/PCC.09m00906yel] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
162 Bernard P, Ninot G. [Benefits of exercise for people with schizophrenia: a systematic review]. Encephale 2012;38:280-7. [PMID: 22980468 DOI: 10.1016/j.encep.2011.07.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
163 Tse J, Chow E, Sultana-cordero R, Titus-prescott M, Chiles R, Cleek A, Cleek E. Motivation-Based Interventions for Obesity in Serious Mental Illness. Psychiatric Annals 2011;41:473-7. [DOI: 10.3928/00485713-20110921-05] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
164 Chacón F, Mora F, Gervás-Ríos A, Gilaberte I. Efficacy of lifestyle interventions in physical health management of patients with severe mental illness. Ann Gen Psychiatry 2011;10:22. [PMID: 21929761 DOI: 10.1186/1744-859X-10-22] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
165 Thompson A, Hetrick SE, Alvarez-Jiménez M, Parker AG, Willet M, Hughes F, Gariup M, Gomez DL, McGorry PD. Targeted intervention to improve monitoring of antipsychotic-induced weight gain and metabolic disturbance in first episode psychosis. Aust N Z J Psychiatry 2011;45:740-8. [PMID: 21827345 DOI: 10.3109/00048674.2011.595370] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
166 Haw C, Stubbs J. What are we doing about weight management in forensic psychiatry? A survey of forensic psychiatrists. British Jnl Forensic Practice 2011;13:183-90. [DOI: 10.1108/14636641111157823] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
167 Holt RIG, Peveler RC. Metabolic Syndrome and Mental Illness. The Metabolic Syndrome 2011. [DOI: 10.1002/9781444347319.ch11] [Reference Citation Analysis]
168 Holt R. Undoing Descartes: integrating diabetes care for those with mental illness: The 2011 Mary MacKinnon lecture. Pract Diab Int 2011;28:270-5. [DOI: 10.1002/pdi.1613] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
169 Buhagiar K, Parsonage L, Osborn DP. Physical health behaviours and health locus of control in people with schizophrenia-spectrum disorder and bipolar disorder: a cross-sectional comparative study with people with non-psychotic mental illness. BMC Psychiatry 2011;11:104. [PMID: 21702897 DOI: 10.1186/1471-244X-11-104] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
170 De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, Newcomer JW, Uwakwe R, Asai I, Möller HJ, Gautam S, Detraux J, Correll CU. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 2011;10:138-51. [PMID: 21633691 DOI: 10.1002/j.2051-5545.2011.tb00036.x] [Cited by in Crossref: 529] [Cited by in F6Publishing: 547] [Article Influence: 44.1] [Reference Citation Analysis]
171 Methapatara W, Srisurapanont M. Pedometer walking plus motivational interviewing program for Thai schizophrenic patients with obesity or overweight: a 12-week, randomized, controlled trial. Psychiatry Clin Neurosci 2011;65:374-80. [PMID: 21682813 DOI: 10.1111/j.1440-1819.2011.02225.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 5.3] [Reference Citation Analysis]
172 Degenhardt EK, Jamal HH, Tormey S, Case M. Early weight gain as a predictor of substantial weight gain with olanzapine/fluoxetine combination: an analysis of 2 adult studies in treatment-resistant depression. J Clin Psychopharmacol 2011;31:337-40. [PMID: 21508852 DOI: 10.1097/JCP.0b013e3182196e64] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
173 McCloughen A, Foster K. Weight gain associated with taking psychotropic medication: an integrative review. Int J Ment Health Nurs 2011;20:202-22. [PMID: 21492360 DOI: 10.1111/j.1447-0349.2010.00721.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 6.3] [Reference Citation Analysis]
174 Goldstein TR, Goldstein BI, Mantz MB, Bailey B, Douaihy A. A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report. J Child Adolesc Psychopharmacol 2011;21:275-80. [PMID: 21663430 DOI: 10.1089/cap.2010.0104] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
175 Ward SL, Ware SG, Kelly C. Prioritising the physical health needs of patients on clozapine. Psychiatrist 2011;35:197-197. [DOI: 10.1192/pb.35.5.197] [Reference Citation Analysis]
176 Ahmed AT, Blair TR, McIntyre RS. Surgical treatment of morbid obesity among patients with bipolar disorder: a research agenda. Adv Ther 2011;28:389-400. [PMID: 21479752 DOI: 10.1007/s12325-011-0015-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
177 Barnes TR; Schizophrenia Consensus Group of British Association for Psychopharmacology. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2011;25:567-620. [PMID: 21292923 DOI: 10.1177/0269881110391123] [Cited by in Crossref: 273] [Cited by in F6Publishing: 275] [Article Influence: 22.8] [Reference Citation Analysis]
178 Uher R, Mors O, Hauser J, Rietschel M, Maier W, Kozel D, Henigsberg N, Souery D, Placentino A, Keers R, Gray JM, Dernovsek MZ, Strohmaier J, Larsen ER, Zobel A, Szczepankiewicz A, Kalember P, Mendlewicz J, Aitchison KJ, McGuffin P, Farmer A. Changes in body weight during pharmacological treatment of depression. Int J Neuropsychopharmacol 2011;14:367-75. [PMID: 20716398 DOI: 10.1017/S1461145710000933] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
179 Jennings E. Diabetes and severe mental illness. British Journal of Wellbeing 2011;2:21-6. [DOI: 10.12968/bjow.2011.2.3.21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
180 de Almeida KM, Moreira CL, Lafer B. Metabolic syndrome and bipolar disorder: what should psychiatrists know? CNS Neurosci Ther 2012;18:160-6. [PMID: 22070636 DOI: 10.1111/j.1755-5949.2011.00240.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
181 Hassapidou M, Papadimitriou K, Athanasiadou N, Tokmakidou V, Pagkalos I, Vlahavas G, Tsofliou F. Changes in body weight, body composition and cardiovascular risk factors after long-term nutritional intervention in patients with severe mental illness: an observational study. BMC Psychiatry 2011;11:31. [PMID: 21332986 DOI: 10.1186/1471-244X-11-31] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
182 Roberts SH, Bailey JE. Incentives and barriers to lifestyle interventions for people with severe mental illness: a narrative synthesis of quantitative, qualitative and mixed methods studies. J Adv Nurs 2011;67:690-708. [PMID: 21323972 DOI: 10.1111/j.1365-2648.2010.05546.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 120] [Article Influence: 9.5] [Reference Citation Analysis]
183 Maayan L, Citrome L. Psychiatric Illness, Psychotropic Medication, and Childhood Obesity. Global Perspectives on Childhood Obesity 2011. [DOI: 10.1016/b978-0-12-374995-6.10025-8] [Reference Citation Analysis]
184 Pagoto S, Schneider K, Appelhans BM, Curtin C, Hajduk A. Psychological Co-morbidities of Obesity. Psychological Co-morbidities of Physical Illness 2011. [DOI: 10.1007/978-1-4419-0029-6_1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
185 Carvajal A, Martín Arias LH, Jimeno N. Antipsychotic drugs. Side Effects of Drugs Annual 2011. [DOI: 10.1016/b978-0-444-53741-6.00006-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
186 Pramyothin P, Khaodhiar L. Metabolic syndrome with the atypical antipsychotics. Curr Opin Endocrinol Diabetes Obes. 2010;17:460-466. [PMID: 20717020 DOI: 10.1097/med.0b013e32833de61c] [Cited by in Crossref: 128] [Cited by in F6Publishing: 129] [Article Influence: 9.8] [Reference Citation Analysis]
187 Van Citters AD, Pratt SI, Jue K, Williams G, Miller PT, Xie H, Bartels SJ. A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness. Community Ment Health J 2010;46:540-52. [PMID: 20012197 DOI: 10.1007/s10597-009-9272-x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 5.5] [Reference Citation Analysis]
188 Smits JA, Rosenfield D, Mather AA, Tart CD, Henriksen C, Sareen J. Psychotropic medication use mediates the relationship between mood and anxiety disorders and obesity: findings from a nationally representative sample. J Psychiatr Res 2010;44:1010-6. [PMID: 20434171 DOI: 10.1016/j.jpsychires.2010.04.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
189 Iglesias-García C, Toimil-Iglesias A, Alonso-Villa MJ. Pilot study of the efficacy of an educational programme to reduce weight, on overweight and obese patients with chronic stable schizophrenia. J Psychiatr Ment Health Nurs 2010;17:849-51. [PMID: 21077409 DOI: 10.1111/j.1365-2850.2010.01590.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
190 Raedler TJ. Cardiovascular aspects of antipsychotics. Curr Opin Psychiatry 2010;23:574-81. [PMID: 20838345 DOI: 10.1097/YCO.0b013e32833f46c9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 4.5] [Reference Citation Analysis]
191 Wildgust HJ, Beary M. Are there modifiable risk factors which will reduce the excess mortality in schizophrenia? J Psychopharmacol 2010;24:37-50. [PMID: 20923919 DOI: 10.1177/1359786810384639] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 4.8] [Reference Citation Analysis]
192 Gothefors D, Adolfsson R, Attvall S, Erlinge D, Jarbin H, Lindström K, von Hausswolff-Juhlin YL, Morgell R, Toft E, Osby U; Swedish Psychiatric Association. Swedish clinical guidelines--prevention and management of metabolic risk in patients with severe psychiatric disorders. Nord J Psychiatry 2010;64:294-302. [PMID: 20662682 DOI: 10.3109/08039488.2010.500397] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
193 Maayan L, Correll CU. Management of antipsychotic-related weight gain. Expert Rev Neurother 2010;10:1175-200. [PMID: 20586697 DOI: 10.1586/ern.10.85] [Cited by in Crossref: 69] [Cited by in F6Publishing: 80] [Article Influence: 5.3] [Reference Citation Analysis]
194 Hasnain M, Fredrickson SK, Vieweg WV, Pandurangi AK. Metabolic syndrome associated with schizophrenia and atypical antipsychotics. Curr Diab Rep. 2010;10:209-216. [PMID: 20425584 DOI: 10.1007/s11892-010-0112-8] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 5.9] [Reference Citation Analysis]
195 Sharpe J, Stedman T, Byrne NM, Hills AP. Prediction of resting energy requirements in people taking weight-inducing antipsychotic medications: Resting metabolic rate with antipsychotic medication usage. Nutrition & Dietetics 2010;67:166-70. [DOI: 10.1111/j.1747-0080.2010.01450.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
196 Bradshaw T, Lovell K, Bee P, Campbell M. The development and evaluation of a complex health education intervention for adults with a diagnosis of schizophrenia. J Psychiatr Ment Health Nurs 2010;17:473-86. [PMID: 20633074 DOI: 10.1111/j.1365-2850.2009.01543.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
197 Abed H. What factors affect the lifestyle choices of people with schizophrenia? Mental Health Review Journal 2010;15:21-7. [DOI: 10.5042/mhrj.2010.0368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
198 Rowell AM, Faruqui RA. Persistent hyperphagia in acquired brain injury; an observational case study of patients receiving inpatient rehabilitation. Brain Inj 2010;24:1044-9. [PMID: 20545458 DOI: 10.3109/02699052.2010.489795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
199 Porsdal V, Beal C, Kleivenes OK, Martinsen EW, Lindström E, Nilsson H, Svanborg P. The Scandinavian Solutions for Wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders. BMC Psychiatry 2010;10:42. [PMID: 20537122 DOI: 10.1186/1471-244X-10-42] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
200 Gleeson JF, Alvarez-Jimenez M, Cotton SM, Parker AG, Hetrick S. A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis. Schizophr Res 2010;119:79-88. [PMID: 20347266 DOI: 10.1016/j.schres.2010.02.1073] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
201 Townsend L, Findling RL. Modifying the risk of atypical antipsychotics in the treatment of juvenile-onset schizophrenia. Expert Opin Pharmacother 2010;11:195-205. [PMID: 20088741 DOI: 10.1517/14656560903473165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
202 Attux C, Martini LC, Reis AF, Bressan RA. [Non-pharmacological interventions for weight gain in patients with schizophrenia taking antipsychotics]. Arq Bras Endocrinol Metabol 2009;53:391-8. [PMID: 19649375 DOI: 10.1590/s0004-27302009000400002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
203 Holt R, Peveler R. Diabetes and cardiovascular risk in severe mental illness: a missed opportunity and challenge for the future: Diabetes and cardiovascular risk in severe mental illness. Pract Diab Int 2010;27:79-84ii. [DOI: 10.1002/pdi.1451] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
204 Scheen A, Gillain B, De Hert M. Maladie cardiovasculaire et diabète chez les personnes atteintes d’une maladie mentale sévère. Médecine des Maladies Métaboliques 2010;4:223-30. [DOI: 10.1016/s1957-2557(10)70049-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
205 Dixon LB, Dickerson F, Bellack AS, Bennett M, Dickinson D, Goldberg RW, Lehman A, Tenhula WN, Calmes C, Pasillas RM, Peer J, Kreyenbuhl J; Schizophrenia Patient Outcomes Research Team (PORT). The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull 2010;36:48-70. [PMID: 19955389 DOI: 10.1093/schbul/sbp115] [Cited by in Crossref: 486] [Cited by in F6Publishing: 518] [Article Influence: 37.4] [Reference Citation Analysis]
206 Alvarez-Jiménez M, Martínez-García O, Pérez-Iglesias R, Ramírez ML, Vázquez-Barquero JL, Crespo-Facorro B. Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial. Schizophr Res 2010;116:16-9. [PMID: 19896336 DOI: 10.1016/j.schres.2009.10.012] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
207 Killackey E. Psychosocial and psychological interventions in early psychosis: essential elements for recovery. Early Interv Psychiatry 2009;3 Suppl 1:S17-21. [PMID: 21352192 DOI: 10.1111/j.1751-7893.2009.00126.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
208 De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Möller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 2009;24:412-24. [PMID: 19682863 DOI: 10.1016/j.eurpsy.2009.01.005] [Cited by in Crossref: 607] [Cited by in F6Publishing: 636] [Article Influence: 43.4] [Reference Citation Analysis]
209 Gabriele JM, Dubbert PM, Reeves RR. Efficacy of behavioural interventions in managing atypical antipsychotic weight gain. Obes Rev 2009;10:442-55. [PMID: 19389059 DOI: 10.1111/j.1467-789X.2009.00570.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
210 Remington G. From mice to men: What can animal models tell us about the relationship between mental health and physical activity? Mental Health and Physical Activity 2009;2:10-5. [DOI: 10.1016/j.mhpa.2009.01.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
211 Kemp V, Bates A, Isaac M. Behavioural interventions to reduce the risk of physical illness in persons living with mental illness. Curr Opin Psychiatry 2009;22:194-9. [PMID: 19553875 DOI: 10.1097/YCO.0b013e328325a585] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
212 George D, Reilly JG, Kwentoh ML. One ace and three faults don't win the set. Br J Psychiatry 2009;194:88-9; author reply 89. [PMID: 19118335 DOI: 10.1192/bjp.194.1.88a] [Reference Citation Analysis]
213 John Wiley & Sons, Ltd.. Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidem Drug Safe 2009;18:i-xiv. [DOI: 10.1002/pds.1644] [Reference Citation Analysis]
214 Alvarez-Jiménez M, González-Blanch C, Crespo-Facorro B, Hetrick S, Rodríguez-Sánchez JM, Pérez-Iglesias R, Vázquez-Barquero JL. Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal. CNS Drugs 2008;22:547-62. [PMID: 18547125 DOI: 10.2165/00023210-200822070-00002] [Cited by in Crossref: 190] [Cited by in F6Publishing: 195] [Article Influence: 12.7] [Reference Citation Analysis]